Risk factors for QT interval prolongation owing to acute gastrointestinal haemorrhage in patients with cirrhosis

Liver InternationalVolume 33, Issue 2 p. 321-321 Letter to the Editor Risk factors for QT interval prolongation owing to acute gastrointestinal haemorrhage in patients with cirrhosis Marko Lehmann, Marko Lehmann Department of Internal Medicine II, Division of Gastroenterology, Hepatology and Infectious Diseases, Jena University Hospital, Jena, GermanySearch for more papers by this authorTony Bruns, Tony Bruns Department of Internal Medicine II, Division of Gastroenterology, Hepatology and Infectious Diseases, Jena University Hospital, Jena, Germany The Integrated Research and Treatment Center for Sepsis Control and Care (CSCC), Jena, GermanySearch for more papers by this authorAndreas Stallmach, Andreas Stallmach Department of Internal Medicine II, Division of Gastroenterology, Hepatology and Infectious Diseases, Jena University Hospital, Jena, Germany The Integrated Research and Treatment Center for Sepsis Control and Care (CSCC), Jena, GermanySearch for more papers by this author Marko Lehmann, Marko Lehmann Department of Internal Medicine II, Division of Gastroenterology, Hepatology and Infectious Diseases, Jena University Hospital, Jena, GermanySearch for more papers by this authorTony Bruns, Tony Bruns Department of Internal Medicine II, Division of Gastroenterology, Hepatology and Infectious Diseases, Jena University Hospital, Jena, Germany The Integrated Research and Treatment Center for Sepsis Control and Care (CSCC), Jena, GermanySearch for more papers by this authorAndreas Stallmach, Andreas Stallmach Department of Internal Medicine II, Division of Gastroenterology, Hepatology and Infectious Diseases, Jena University Hospital, Jena, Germany The Integrated Research and Treatment Center for Sepsis Control and Care (CSCC), Jena, GermanySearch for more papers by this author First published: 01 November 2012 https://doi.org/10.1111/liv.12010Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References 1Trevisani F, Di Micoli A, Zambruni A, et al. QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosis. Liver Int 2012; 32: 1510– 5. 2Zambruni A, Trevisani F, Caraceni P, et al. Cardiac electrophysiological abnormalities in patients with cirrhosis. J Hepatol 2006; 44: 994– 1002. 3Lehmann M, Bruns T, Herrmann A, et al. 54-year-old male with hepatic cirrhosis and therapy-associated torsade de pointes tachycardia. Internist 2011; 52: 450. 4Feu F, Ruiz del Arbol L, Bañares R, et al. Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Variceal Bleeding Study Group. Gastroenterology 1996; 111: 1291– 9. 5Urge J, Sincl F, Procházka V, et al. Terlipressin-induced ventricular arrhythmia. Scand J Gastroenterol 2008; 43: 1145– 8. 6Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Avila F, et al. Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding – an updated Cochrane review. Aliment Pharmacol Ther 2011; 34: 509– 18. Volume33, Issue2February 2013Pages 321-321 ReferencesRelatedInformation